Table 1.
Frequency of Th1, Th2, Th17, and Treg cells in controls and patients with UCC, CIN, or HPV (%, x̅ ± s)
| Th1 cell | Th2 cell | Th17 cell | Treg cell | |
|---|---|---|---|---|
| Control group (n=20) | 23.12±2.81 | 2.11±0.99 | 1.23±0.41 | 2.00±0.66 |
| HPV group (n=20) | 20.43±3.13 | 3.22±1.47 | 1.44±0.49 | 2.86±0.87a |
| CIN group (n=61) | 16.24±3.76a,b | 4.53±1.55a,b | 7.61±2.49a,b | 4.29±0.8a,b |
| UCC group (n=38) | 9.09±1.56a,b,c | 9.77±2.19a,b,c | 12.41±2.09a,b,c | 5.38±1.14a,b,c |
Compared to the control group;
a
P<0.05.
Compared to the HPV group;
b
P<0.05.
Compared to the CIN group;
c
P<0.05.